Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-12

Clinical Trial Update: Optimal Methods of Disease Progression and Survival Analysis in Children and Adults Patients With Adrenocortical Cancer (ACC)

View source ↗

Summary

A clinical trial update focusing on optimal methods for assessing disease progression and survival in children and adults with adrenocortical carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adrenocortical Carcinoma | Status: ACTIVE_NOT_RECRUITING